Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySat, 06 Jul 2024 07:22:37 +0200Thu, 11 Apr 2024 10:44:00 +0200Human medicines European public assessment report (EPAR): Ambrisentan Mylan, ambrisentan, Date of authorisation: 20/06/2019, Revision: 5, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ambrisentan-mylanHuman medicines European public assessment report (EPAR): Ambrisentan Mylan, ambrisentan, Date of authorisation: 20/06/2019, Revision: 5, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ambrisentan-mylanThu, 11 Apr 2024 10:44:00 +0200Human medicineAmbrisentan Mylan : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4985-en.pdfAmbrisentan Mylan : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4985-en.pdfThu, 11 Apr 2024 10:38:00 +0200Human medicine